Chung I, Schlichter L C
Department of Physiology, University of Toronto, Ontario, Canada.
J Membr Biol. 1997 Mar 1;156(1):73-85. doi: 10.1007/s002329900189.
The voltage-gated potassium channel, Kv1.3, which is highly expressed in a number of immune cells, contains concensus sites for phosphorylation by protein kinase C (PKC). In lymphocytes, this channel is involved in proliferation-through effects on membrane potential, Ca2+ signalling, and interleukin-2 secretion-and in cytotoxic killing and volume regulation. Because PKC activation (as well as increased intracellular Ca2+) is required for T-cell proliferation, we have studied the regulation of Kv1.3 current by PKC in normal (nontransformed) human T lymphocytes. Adding intracellular ATP to support phosphorylation, shifted the voltage dependence of activation by +8 mV and inactivation by +17 mV, resulting in a 230% increase in the window current. Inhibiting ATP production and action with "death brew" (2-deoxyglucose, adenylylimidodiphosphate, carbonyl cyanide-m-chlorophenyl hydrazone) reduced the K+ conductance (GK) by 41 +/- 2%. PKC activation by 4 beta-phorbol 12,13-dibutyrate, increased GK by 69 +/- 6%, and caused a positive shift in activation (+9 mV) and inactivation (+9 mV), which resulted in a 270% increase in window current. Conversely, several PKC inhibitors reduced the current. Diffusion into the cell of inhibitory pseudosubstrate or substrate peptides reduced GK by 43 +/- 5% and 38 +/- 8%, respectively. The specific PKC inhibitor, calphostin C, potently inhibited Kv1.3 current in a dose- and light-dependent manner (IC50 approximately 250 nM). We conclude that phosphorylation by PKC upregulates Kv1.3 channel activity in human lymphocytes and, as a result of shifts in voltage dependence, this enhancement is especially prevalent at physiologically relevant membrane potentials. This increased Kv1.3 current may help maintain a negative membrane potential and a high driving force for Ca2+ entry in the presence of activating stimuli.
电压门控钾通道Kv1.3在多种免疫细胞中高度表达,含有蛋白激酶C(PKC)磷酸化的共有位点。在淋巴细胞中,该通道通过对膜电位、Ca2+信号传导和白细胞介素-2分泌的影响参与增殖,并参与细胞毒性杀伤和体积调节。由于T细胞增殖需要PKC激活(以及细胞内Ca2+增加),我们研究了正常(未转化)人T淋巴细胞中PKC对Kv1.3电流的调节。添加细胞内ATP以支持磷酸化,使激活的电压依赖性正向移动8 mV,失活的电压依赖性正向移动17 mV,导致窗口电流增加230%。用“死亡混合剂”(2-脱氧葡萄糖、腺苷酰亚胺二磷酸、羰基氰化物间氯苯腙)抑制ATP产生和作用,使K+电导(GK)降低41±2%。4β-佛波醇12,它激活PKC,使GK增加69±6%,并使激活(+9 mV)和失活(+9 mV)正向移动,导致窗口电流增加270%。相反,几种PKC抑制剂降低了电流。抑制性假底物或底物肽扩散到细胞中分别使GK降低43±5%和38±8%。特异性PKC抑制剂钙泊三醇以剂量和光依赖性方式有效抑制Kv1.3电流(IC50约为250 nM)。我们得出结论,PKC磷酸化上调人淋巴细胞中Kv1.3通道活性,并且由于电压依赖性的改变,这种增强在生理相关膜电位下尤为普遍。这种增加的Kv1.3电流可能有助于在存在激活刺激的情况下维持负膜电位和高Ca2+内流驱动力。